Essex Bio-Technology Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Essex Bio-Technology Limited with three other
pharmaceutical manufacturers in Asia:
Panacea Biotec Ltd
sales of 6.53 billion Indian Rupees [US$99.79 million]
of which 59%
Chongqing Zhifei Biological Products Co Ltd
(445.92 million Chinese Renmimbi [US$64.77 million]
of which 99%
was Biological Product), and
based in South Korea
(133.26 billion Korean Won [US$119.26 million]
of which 100%
Essex Bio-Technology Limited reported sales of HK$775.66 million (US$99.88 million)
December of 2016.
increase of 18.6%
versus 2015, when the company's sales were HK$654.01 million.
Sales at Essex Bio-Technology Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 265%).